Discontinuation report M-ESCITALOPRAM
Report ID | 108922 |
Drug Identification Number | 02471426 |
Brand name | M-ESCITALOPRAM |
Common or Proper name | Escitalopram |
Company Name | MANTRA PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | ESCITALOPRAM |
Strength(s) | 20MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | N06AB |
ATC description | ANTIDEPRESSANTS |
Reason for discontinuation | Other (Please describe in comments) |
Anticipated discontinuation date | 2020-06-19 |
Actual discontinuation date | |
Remaining supply date | 2020-06-19 |
Discontinuation status | To be discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | Switch to another format (Blister of 30 tablets) |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1000 RUE DU LUX SUITE 201 BROSSARD, QUEBEC CANADA J4Y 0E3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2020-03-18 | French | Compare |
v2 | 2020-03-18 | French | Compare |
v1 | 2020-03-18 | English | Compare |
Showing 1 to 3 of 3